Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk

Diabetologia

Volumn 52, Issue 9, 2009, Pages 1881-1888

  Achenbach, P ^a,b   Lampasona, V ^c   Landherr, U ^a   Koczwara, K ^a   Krause, S ^b   Grallert, H ^a   Winkler, C ^a   Pfluger M ^a   Illig, T ^a   Bonifacio, E ^d   Ziegler, A G ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; INSULINOMA ASSOCIATED PROTEIN 2; INSULINOMA ASSOCIATED PROTEIN 34; INSULINOMA ASSOCIATED PROTEIN 42; PANCREAS ISLET CELL ANTIBODY; PROTEIN A; SLC30A8 PROTEIN; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8;

ARTICLE; AUTOIMMUNITY; CHILD; DISEASE COURSE; FAMILY HISTORY; FOLLOW UP; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADOLESCENT; AUTOANTIBODIES; CATION TRANSPORT PROTEINS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FOLLOW-UP STUDIES; GENOTYPE; GERMANY; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN ANTIBODIES; LIFE TABLES;

EID: 68449094246     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1438-0     Document Type: Article

References (28)

1. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229
2. Achenbach P, Bonifacio E, Ziegler AG (2005) Predicting type 1 diabetes. Curr Diab Rep 5:98-103
3. Bingley PJ, Gale EA (2006) Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 49:881-890
4. Krischer JP, Cuthbertson DD, Yu L et al (2003) Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab 88:103-108
5. Achenbach P, Warncke K, Reiter J et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384-392
6. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG (2004) Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 140:882-886
7. Chimienti F, Devergnas S, Favier A, Seve M (2004) Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53:2330-2337
8. Wenzlau JM, Juhl K, Yu L et al (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 104:17040-17045
9. Wenzlau JM, Liu Y, Yu L et al (2008) A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 57:2693-2697
10. Kawasaki E, Uga M, Nakamura K et al (2008) Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes. Diabetologia 51:2299-2302
11. Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881-885
12. Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336
13. Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genomewide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341-1345
14. Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336-1341
15. Gohlke H, Ferrari U, Koczwara K, Bonifacio E, Illig T, Ziegler AG (2008) SLC30A8 (ZnT8) polymorphism is associated with young age at type 1 diabetes onset. Rev Diabet Stud 5:25-27
16. Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460-468
17. Naserke HE, Bonifacio E, Ziegler AG (1999) Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: sensitive early detection using a protein A/G-based radiobinding assay. J Clin Endocrinol Metab 84:1239-1243
18. Torn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ (2008) Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 51:846-852
19. Tai MM (1994) A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 17:152-154
20. Kimpimaki T, Kulmala P, Savola K et al (2002) Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 87:4572-4579
21. Barker JM, Barriga KJ, Yu L et al (2004) Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 89:3896-3902
22. Colman PG, Steele C, Couper JJ et al (2000) Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody. Diabetologia 43:203-209
23. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E (2004) Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 114:589-597
24. Mayr A, Schlosser M, Grober N et al (2007) GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes 56:1527-1533
25. Christie MR, Genovese S, Cassidy D et al (1994) Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43:1254-1259
26. Notkins AL, Lan MS, Leslie RD (1998) IA-2 and IA-2beta: the immune response in IDDM. Diabetes Metab Rev 14:85-93
27. Decochez K, de Leeuw IH, Keymeulen B et al (2002) IA-2 autoantibodies predict impending Type I diabetes in siblings of patients. Diabetologia 45:1658-1666
28. Achenbach P, Bonifacio E, Williams AJ, Ziegler AG, Gale EA, Bingley PJ (2008) Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives. Diabetologia 51:488-492